CDKN1A and metabolic dysfunction-associated steatohepatitis: Indeed, in the present study, we demonstrated a substantial decrease in the levels of E2F1, PTEN, and CDKN1A proteins during the development of NASH-derived HCC, which is in a good agreement with our previous report of prominent inhibition of apoptosis during NASH-associated liver carcinogenesis [20].